NCTId,BriefTitle,OverallStatus,Phase,Conditions,Interventions,StudyType,StartDate,PrimaryCompletionDate,Enrollment
NCT00379769,RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes,COMPLETED,PHASE3,"Diabetes Mellitus, Type 2",DRUG: Rosiglitazone; DRUG: Sulfonylurea; DRUG: Metformin,INTERVENTIONAL,2001-04,2008-12,
NCT06367166,Effects of Bioflavanoids on Vascular Wall Remodeling in Patients With Varicose Veins,ACTIVE_NOT_RECRUITING,NA,Varicose Veins of Lower Limb; Varix; Vascular Diseases; Leg Edema,"DRUG: ""Venarus®"" (diosmin and hesperidin); PROCEDURE: Endovenous laser ablation (EVLA) with miniphlebectomy; OTHER: Elastic compression; OTHER: Evaluation of biomarkers of venous wall remodeling (fibronectin, PAI-1, vimentin, vWF, CD31), venous symptoms and severity scores",INTERVENTIONAL,2023-04-01,2026-04-01,
NCT01161394,"Effect of Pioglitazone on Oxidative Load, Inflammatory End-Points and Vascular Reactivity in Obese Non-Diabetic Patients: A Dose Ranging Study",COMPLETED,PHASE4,Inflammation,DRUG: Pioglitazone 15mg; DRUG: pioglitazone 30mg; DRUG: placebo,INTERVENTIONAL,,,
NCT04262960,"Effect of Continuous Positive Airway Pressure on Chronotype, Dietary Intake, and Cardiovascular Risk Markers",UNKNOWN,NA,Obstructive Sleep Apnea of Adult,DEVICE: Device: active CPAP; DEVICE: Device: sham-CPAP,INTERVENTIONAL,2019-08-01,2020-04,
NCT00669435,Losartan and Simvastatin in Hypertensive Obeses With Liver Steatosis,UNKNOWN,PHASE4,Hypertension,DRUG: Losartan + Simvastatin; DRUG: Amlodipine + Simvastatin,INTERVENTIONAL,2008-04,2008-04,
NCT04582188,The Early Coagulopathy for the Prognosis in Sepsis,UNKNOWN,,"Sepsis; Coagulopathy; Outcome, Fatal",,OBSERVATIONAL,2020-11-05,2021-03-31,
NCT02176941,Telomeres and Arterial Aging,UNKNOWN,,Atherosclerotic Disease,,OBSERVATIONAL,2014-06,2016-11,
NCT06051461,Deciphering the Role of Dietary Fatty Acids on Extracellular Vesicles-mediated Intercellular Communication,ACTIVE_NOT_RECRUITING,NA,Obesity; Metabolic Syndrome; Metabolic Disorder; Inflammation; Immune System and Related Disorders,DIETARY_SUPPLEMENT: Oral lipid emulsions,INTERVENTIONAL,2023-11-01,2024-09-01,
NCT05645887,Human Albumin Treatment in Adult Septic Shock. A Study Evaluating Immune Response and Organ Failure.,WITHDRAWN,PHASE2,Septic Shock,DRUG: Human albumin; OTHER: Saline solution,INTERVENTIONAL,2024-02,2024-05-23,
NCT06382298,Cottonseed Oil Versus Matched PUFA Effects,RECRUITING,NA,"Dyslipidemia; Overweight and Obesity; Nutrition, Healthy",OTHER: COTTONSEED OIL; OTHER: MATCHED PUFA DIET; OTHER: CONTROL,INTERVENTIONAL,2024-08-31,2026-12,
NCT01101204,The Effects of Hypolipemic and Antidiabetic Treatment on Cytokines,UNKNOWN,NA,Diabetes; Dyslipidemia; Inflammation; Cytokines,"DRUG: Metformin 1000mg, simvastatin 10mg and fenofibrate 100mg",INTERVENTIONAL,2012-07,2012-10,
NCT06680180,Fibrinolysis Resistance in Infection and Trauma,RECRUITING,,Sepsis and Septic Shock; Trauma,DIAGNOSTIC_TEST: Viscoelastometric assessment of fibrinolysis,OBSERVATIONAL,2024-06-01,2025-12-31,
NCT03208166,Pilot Study of Pre-Ischemic Conditioning for Intracranial Atherosclerosis,COMPLETED,NA,Intracranial Atherosclerosis,DEVICE: Doctormate; OTHER: Usual Care,INTERVENTIONAL,2017-06-15,2018-05-30,
NCT05490394,Correlation Study of PAI-1 4G/5G Polymorphism and Postoperative AKI in Patients With Aortic Dissection,COMPLETED,,AKI - Acute Kidney Injury; PAI-1 4G/5G Polymorphism; Aortic Dissection,,OBSERVATIONAL,2022-04-28,2022-06-16,
NCT06235853,Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer,COMPLETED,,Non-muscle Invasive Bladder Cancer; Cystoscopy; Recurrence; Progression; Bladder Cancer; Biomarkers,"DIAGNOSTIC_TEST: Blood serum: sUPAR, PAI-1, IL-8.; DIAGNOSTIC_TEST: Urine: IL-8, APOE, VEGF.",OBSERVATIONAL,2020-01-01,2022-12-31,
NCT01916408,The Effects of Enzymes and Flavonoids on Inflammation and Coagulation After Marathon,COMPLETED,PHASE1,"Inflammation; Death, Sudden, Cardiac; Death; Heart Diseases; Cardiovascular Diseases; Pathologic Processes; Death, Sudden; Blood Coagulation Disorders; Respiratory Tract Infections",DRUG: Wobenzym plus; DRUG: PL 1,INTERVENTIONAL,2013-08,2014-01,
NCT00371982,Effect of Fish Oil on Adiposity and Atherogenic Factors in Type 2 Diabetic Women,TERMINATED,NA,Type 2 Diabetes,DRUG: Fish oil (Maxepa),INTERVENTIONAL,2002-12,,
NCT05246774,Study of Serum and Urinary Biomarkers and Radiation Cystitis in Patients Treated With Radiotherapy for Localized Prostate Cancer,UNKNOWN,,Radiation Cystitis; Prostate Cancer; Radiotherapy Side Effect,BIOLOGICAL: Biological sample collection; OTHER: Questionnaires,OBSERVATIONAL,2022-03-01,2024-09,
NCT06454045,Evaluation of Platelet Aggregability in Patients With Previous Acute Myocardial Infarction or Concomitant Lower Extremity Peripheral Artery Disease,ACTIVE_NOT_RECRUITING,,Coronary Artery Disease; Peripheral Arterial Disease,DRUG: Clopidogrel,OBSERVATIONAL,2024-05-13,2026-05-13,
NCT06503809,Efficacy and Safety of a Ketogenic Diet in Type 1 Diabetes,RECRUITING,NA,"Diabetes Mellitus, Type 1",BEHAVIORAL: Ketogenic Diet; BEHAVIORAL: Standard Diet,INTERVENTIONAL,2024-08-12,2029-03-31,
NCT06467643,Minimally Invasive Root Canal Treatment With Active Disinfection on Single Rooted Teeth With Periapical Lesions,COMPLETED,NA,Radiographic Healing of Periapical Lesions Following Ultrasonic Activation of Heated Sodium Hypochlorite Without Instrumentation of Root Canals,PROCEDURE: non-instrumented root canal treatment with passive ultrasonic activation of heated sodium hypochlorite; PROCEDURE: conventional root canal treatment with passive ultrasonic activation of heated sodium hypochlorite,INTERVENTIONAL,2023-07-07,2023-10-07,
NCT01441921,Effect of Pistachio Intake on Insulin Resistance and Type 2 Diabetes Mellitus,COMPLETED,NA,Type 2 Diabetes Mellitus,DIETARY_SUPPLEMENT: Pistachios; OTHER: control diet,INTERVENTIONAL,2011-09,2016-09,
NCT02251795,"Effects of Steady State Tipranavir/Ritonavir or Darunavir/Ritonavir or Ritonavir on Platelet Function, Coagulation and Fibrinolysis Biomarkers in Healthy Subjects",COMPLETED,PHASE1,Healthy,DRUG: Tipranavir; DRUG: Ritonavir; DRUG: Darunavir; DRUG: Aspirin,INTERVENTIONAL,2007-08,2008-06,
NCT00667498,Metabolic Effect of Metformin in Obese Insulin Resistant Adolescents With Normal Glucose Tolerance,COMPLETED,PHASE4,Pediatric Obesity; Insulin Resistance; Hyperinsulinemia,DRUG: Metformin; DRUG: Placebo,INTERVENTIONAL,2004-03,2007-12,
NCT06422494,The Role of the Adrenergic System in Hypoglycaemia Induced Inflammatory Response in People With Type 1 Diabetes and People Without Type 1 Diabetes-RAID-II,ACTIVE_NOT_RECRUITING,NA,"Diabetes Mellitus, Type 1; Inflammation",DRUG: hyperinsulinaemic hypoglycaemic clamp; DRUG: Propranolol Hydrochloride 1 MG/ML; DRUG: Phentolamine,INTERVENTIONAL,2025-01-01,2025-09,
NCT03552757,Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity,COMPLETED,PHASE3,Obesity; Overweight,DRUG: Semaglutide 1.0 mg; DRUG: Semaglutide 2.4 mg; DRUG: Placebo I (Semaglutide); DRUG: Placebo II (Semaglutide),INTERVENTIONAL,2018-06-04,2020-03-24,
NCT03903302,Study Investigation Pharmacokinetics and Pharmacodynamics of CS1,COMPLETED,PHASE1,Thrombosis,DRUG: CS1-Sodium Valproate,INTERVENTIONAL,2017-10-06,2018-02-28,
NCT02284230,The Effect of Liraglutide in Patients With Prediabetes and Kidney Failure,WITHDRAWN,PHASE2,"Kidney Failure, Chronic; Prediabetic State",DRUG: Liraglutide; DRUG: Placebo,INTERVENTIONAL,2014-12,2015-08,
NCT00092157,Effectiveness of Two Approved Drugs in Lowering High Cholesterol (0733-224),COMPLETED,PHASE3,Hypercholesterolemia,"DRUG: MK0733, simvastatin; DRUG: Comparator: simvastatin",INTERVENTIONAL,2002-05-01,2003-03-03,
NCT04109742,Curcumin for Pediatric Nonalcoholic Fatty Liver Disease,WITHDRAWN,PHASE2,NAFLD - Nonalcoholic Fatty Liver Disease; NASH - Nonalcoholic Steatohepatitis,DRUG: phosphatidylcholine-curcumin complex supplement; DRUG: Placebo curcumin capsule,INTERVENTIONAL,2019-12-09,2020-04-22,
NCT06935942,The Associations of Plasminogen Activator Inhibitor-1 Gene Polymorphisms With Crohn's Disease in Chinese Patients,COMPLETED,,Crohn Disease,BIOLOGICAL: Ustekinumab - Standard Dosage,OBSERVATIONAL,2020-01-01,2025-01-01,
NCT05583305,Prevalence and Etiologies of Intracranial Stenosis in Patients With Antiphospholipid Syndrome,ENROLLING_BY_INVITATION,,Antiphospholipid Syndrome; Stenosis; Intracranial Stenosis,DIAGNOSTIC_TEST: Imaging assessment; DIAGNOSTIC_TEST: Neurosonology assessment; DIAGNOSTIC_TEST: Blood Test,OBSERVATIONAL,2022-10-12,2026-01-31,
NCT00662805,Pharmacovigilance Study to Evaluate Safety of SERETIDE in Participants With Chronic Obstructive Pulmonary Disease (COPD),COMPLETED,,"Pulmonary Disease, Chronic Obstructive",DRUG: Salmeterol/Fluticasone propionate,OBSERVATIONAL,2004-06,2008-09,
NCT03811574,STEP 6: Research Study Investigating How Well Semaglutide Works in People Living With Overweight or Obesity,COMPLETED,PHASE3,Overweight; Obesity,DRUG: Semaglutide; DRUG: Placebo (semaglutide),INTERVENTIONAL,2019-01-21,2020-11-20,
NCT00395512,Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes Mellitus,COMPLETED,PHASE3,Diabetes Mellitus,DRUG: Alogliptin; DRUG: Pioglitazone; DRUG: Placebo,INTERVENTIONAL,2006-11,2008-02,
NCT00608465,Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity,TERMINATED,PHASE4,Metabolic Syndrome X,DRUG: Eplerenone; DRUG: Ramipril,INTERVENTIONAL,2006-05,2009-05,
NCT02186353,Processing Responses of Grains (PRO-Grains) Study,WITHDRAWN,NA,Insulin Resistance; Cardiovascular Disease; Diabetes,BEHAVIORAL: Partial feeding study,INTERVENTIONAL,2014-09,2015-09,
NCT03236272,Establishment of a Biomarkers-based Early Warning System of Acute Respiratory Distress Syndrome (ARDS),UNKNOWN,,"Respiratory Distress Syndrome, Adult",,OBSERVATIONAL,2017-09-15,2020-12-31,
NCT05652972,"Effect of KETOgenic Diet on Metabolism, Inflammation, Nutrition Deficiencies and OXidative Stress in Women With Overweight",ACTIVE_NOT_RECRUITING,NA,Overweight and Obesity,OTHER: Ketogenic diet; OTHER: Control diet,INTERVENTIONAL,2023-02-01,2024-05-30,
NCT05330819,Thrombogenicity of Lipoprotein A: Laboratory Study Defining the Prothrombotic Effects of Lipoprotein A,UNKNOWN,,Cardiovascular Disease and Lipid Disorders; Cardiac Disease,OTHER: Non-interventional,OBSERVATIONAL,2022-05-01,2022-08,
NCT00385931,Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin,COMPLETED,PHASE3,Hypertension; Hypercholesterolemia; Dyslipidemia,DRUG: Valsartan and simvastatin,INTERVENTIONAL,2002-01,2003-04,
NCT02225834,Atorvastatin in Acute Stroke Treatment,COMPLETED,PHASE4,Ischemic Stroke,DRUG: Atorvastatin,INTERVENTIONAL,2011-11,2014-01,
NCT02238821,Role of the MET Oncogene in Human Colorectal Cancer - A Translational Study,COMPLETED,,Colorectal Cancer,,OBSERVATIONAL,2007-10,2016-09,
NCT05789108,Deep Venous Thrombosis and Long Term Complications,RECRUITING,NA,DVT of Legs,DIAGNOSTIC_TEST: Blood sample and Ultrasound examination,INTERVENTIONAL,2023-03-14,2026-03-09,
NCT03012633,Rapid Diagnostic of Hyperfibrinolysis in Liver Transplantation,COMPLETED,,Liver Transplantation,DEVICE: Lysis timer,OBSERVATIONAL,2017-01-09,2017-06-14,
NCT00500955,Rosiglitazone on Microalbuminuria in Type 2 Diabetics,COMPLETED,PHASE3,"Diabetes Mellitus, Type 2",DRUG: Rosiglitazone,INTERVENTIONAL,2000-04,,
NCT06275906,"Influence of a Mediterranean Diet Combined With a Physical Activity Intervention, on NAFLD and Inflammation Parameters.",RECRUITING,NA,NAFLD; Obesity; IBS,OTHER: Mediterranean diet and moderate intensity physical exercise (outdoor walking).,INTERVENTIONAL,2024-03-19,2025-04-08,
NCT03844035,Impacts of Oral Irrigation in Patients With Periimplant Mucositis,COMPLETED,NA,Peri-implant Mucositis,DIAGNOSTIC_TEST: Periimplant crevicular fluid (PICF) collection,INTERVENTIONAL,2014-11-06,2015-05-04,
NCT04389125,Efficacy and Safety of Angelica Gigas Nakai and Allium Cepa L.Extract Mixtures on the Improvement of Blood Flow,UNKNOWN,NA,Blood Flow,DIETARY_SUPPLEMENT: Angelica Gigas Nakai and Allium Cepa L.Extract Mixtures; DIETARY_SUPPLEMENT: Placebo,INTERVENTIONAL,2020-01-30,2021-04-30,
NCT03855501,Apexification Treatment With MTA(Mineral Trioxide Aggregate) and Ca(OH)2,COMPLETED,NA,Immature Teeth,OTHER: Mineral trioxide aggregate; OTHER: Calcium hydroxide,INTERVENTIONAL,2015-01,2019-01,
NCT01704274,GTN Therapy on Biomarkers of Immune Escape in Men With Biochemical Recurrence of Prostate Cancer After Primary Therapy,COMPLETED,PHASE2,Prostate Cancer,OTHER: Low Dose GTN 0.0285 mg/hr; OTHER: High Dose GTN 0.057 mg/hr; OTHER: Placebo,INTERVENTIONAL,2012-04,2017-01,
NCT02310191,Correlation Between Laboratory Markers and Origin of New Brain Ischemic Lesions After Carotid Stenting,COMPLETED,,Carotid Stenosis; Brain Ischemia; Laboratory Problem,PROCEDURE: Carotid stenting,OBSERVATIONAL,2012-07,2014-11,
NCT05588479,Pomegranate Extract and Inflammageing,COMPLETED,NA,Aging,DIETARY_SUPPLEMENT: Pomegranate extract; DIETARY_SUPPLEMENT: Control,INTERVENTIONAL,2022-12-10,2024-06-30,
NCT05713461,Physical Exercise in Obesity for Health and Quality of Life.,COMPLETED,NA,Obesity; Overweight and Obesity; Overweight or Obesity,BEHAVIORAL: exercise training program; BEHAVIORAL: Feeding training,INTERVENTIONAL,2022-10-26,2023-05-31,
NCT05847647,Evaluation of the Effect of Leukocyte and Platelet-rich Fibrin on Healing After Periradicular Surgery,ACTIVE_NOT_RECRUITING,NA,Apical Periodontitis; Periapical Lesion,OTHER: Retrograde Filling Group; OTHER: Retrograde Filling+L-PRF Group; OTHER: (Orthograde Filling Group / OG Group).; OTHER: (Orthograde Filling+L-PRF Group,INTERVENTIONAL,2022-02-07,2023-03-02,
NCT01696448,"The BANGALORE Study; Combination of Berberine, Lipoic Acid, and Picrorhiza",COMPLETED,NA,Metabolic Syndrome,DIETARY_SUPPLEMENT: CAR-191; OTHER: Placebo,INTERVENTIONAL,2012-08,2013-04,
NCT03124108,Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid,COMPLETED,PHASE2,Primary Biliary Cholangitis (PBC),DRUG: Elafibranor 80 mg; DRUG: Elafibranor 120 mg; DRUG: Placebo,INTERVENTIONAL,2017-04-05,2018-10-31,
NCT01559415,An Adipocyte-Driven Mechanism For Weight Regain After Weight Loss: The Yo-Yo Effect,COMPLETED,NA,Obesity; Weight Loss; Diet,OTHER: Meal replacement diet using Modifast; OTHER: Normal diet combined with Modifast diet,INTERVENTIONAL,2012-03,2014-11,
NCT05496868,Add-on Reparixin in Adult Patients With ARDS,COMPLETED,PHASE2,"Acute Respiratory Distress Syndrome, Adult",DRUG: Reparixin 600mg; OTHER: Matching Placebo,INTERVENTIONAL,2022-12-06,2025-03-18,
NCT03347591,Rare Bleeding Disorders in the Netherlands,UNKNOWN,,Rare Bleeding Disorders,GENETIC: WES; DIAGNOSTIC_TEST: Several assays,OBSERVATIONAL,2017-11-07,2021-07-01,
NCT01261390,Sleep Apnea Intervention for Cardiovascular Disease Reduction,COMPLETED,NA,Obstructive Sleep Apnea,BEHAVIORAL: Conservative Medical Therapy (CMT); DEVICE: Sham PAP (Sham); DEVICE: Active PAP with RT Support (Active-Beh); DEVICE: Active PAP with Behavioral Modification (Active+Beh),INTERVENTIONAL,2011-03,2014-03,
NCT03424460,Venous Thromboembolism in Myotonic Dystrophy Type 1,COMPLETED,NA,Myotonic Dystrophy 1,BIOLOGICAL: Haemostasis tests; BIOLOGICAL: Monocytes and megacaryocytes culture and RNA extraction; GENETIC: RNA extraction,INTERVENTIONAL,2018-06-11,2023-03-15,
NCT05746013,Lipoproteins and ImmunoMetabolism,ACTIVE_NOT_RECRUITING,NA,Obesity; Metabolic Syndrome; Metabolism Disorder; Inflammation; Immune System and Related Disorders,DIETARY_SUPPLEMENT: Lipid Emulsion,INTERVENTIONAL,2020-02-01,2023-05,
NCT01293175,Whole Grain Polyphenol Bioavailability and Effects on Health,COMPLETED,NA,Overweight,DIETARY_SUPPLEMENT: Whole grains,INTERVENTIONAL,2011-02,2012-02,
NCT02876601,Defibrotide in the Human Endotoxemia Model --- an Exploratory Trial Investigating the Effects and the Mechanisms of Defibrotide,COMPLETED,PHASE4,Healthy Volunteers; Endotoxemia,DRUG: Defibrotide; DRUG: Placebo (0.9% sodium chloride); DRUG: Lipopolysaccharide; DRUG: Placebo (0.9% sodium chloride bolus),INTERVENTIONAL,2017-04-18,2018-02-12,
NCT02548689,PAI-1 Expression in Non-scarring Hair Loss,TERMINATED,,Androgenetic Alopecia; Telogen Effluvium; Alopecia Areata,,OBSERVATIONAL,2015-07,2021-06,
NCT01087086,Reduction of the Metabolic Syndrome in Navarra-Spain,COMPLETED,NA,Metabolic Syndrome; Obesity; Diabetes; Cardiovascular Disease,BEHAVIORAL: Crononutrition; BEHAVIORAL: American Heart Association,INTERVENTIONAL,2010-01,2010-12,
NCT05379205,Multidisciplinary Prehabilitation and Postoperative Rehabilitation in Patients Undergoing Resection of Colon Cancer,ACTIVE_NOT_RECRUITING,NA,Colon Cancer; Postoperative Complications,BEHAVIORAL: Prehabilitation program (4 week before the surgery); BEHAVIORAL: Postoperative program (12 week after the surgery); OTHER: Usual Care,INTERVENTIONAL,2022-11-01,2025-07-17,
NCT01409382,Maternal Lifestyle and Neonatal Hypoglycemia,COMPLETED,NA,Hyperinsulinemia; Miscarriages; Pregnancy; Sedentary Lifestyle; Hypoglycemia,BEHAVIORAL: Daily brisk walking plus a carbohydrate-restricted diet,INTERVENTIONAL,2011-03,2013-04,
NCT01906359,Effects of Triacylglycerol Structure on Gut Hormones and Haemostatic Markers,COMPLETED,NA,Type 2 Diabetes Mellitus,OTHER: Native palm olein (IV56); OTHER: Chemically interesterified palm olein (IV56); OTHER: High oleic sunflower oil,INTERVENTIONAL,2012-09,2013-07,
NCT01397682,Epidemiological Observatory on the Health Conditions of Inpatients Aged 65 or Older at the INRCA Research Hospitals,ENROLLING_BY_INVITATION,,Aging; Inpatients,OTHER: blood sample collection,OBSERVATIONAL,2011-05-05,2025-05,
NCT00884819,Effects of Fenofibrate on Metabolic and Reproductive Parameters in Polycystic Ovary Syndrome,TERMINATED,NA,Polycystic Ovary Syndrome,DRUG: Fenofibrate; OTHER: Placebo,INTERVENTIONAL,2008-12,2015-02,
NCT01816165,"Effects of Acipimox on Insulin Action, Vascular Function, and Muscle Function in Type 1 Diabetes",COMPLETED,PHASE3,Type 1 Diabetes,DRUG: Acipimox; DRUG: Placebo,INTERVENTIONAL,2011-06,2015-06-24,
NCT00777647,Effect of Carbonated Soft Drinks on the Body Weight,COMPLETED,NA,Obesity; Metabolic; Complications; Dietary Habits,OTHER: Sugar-sweetened soft drink; OTHER: Aspartame-sweetened soft drink; OTHER: Semi-skimmed milk; OTHER: Water,INTERVENTIONAL,2008-05,2010-12,
NCT06150079,Individualized PEEP Titration on Postoperative Pulmonary Complications,COMPLETED,NA,Postoperative Pulmonary Complications; Positive End-expiratory Pressure; Elderly; Laparoscopic Surgery,PROCEDURE: Pes-Guided PEEP titration,INTERVENTIONAL,2023-11-30,2024-11-18,
NCT02862223,A Study Investigating the Effects of Neprinol Study Product on Vascular Function,COMPLETED,PHASE2,Obesity; Overweight,DIETARY_SUPPLEMENT: Neoprinol,INTERVENTIONAL,2012-03,2014-03,
NCT01337882,"Biodiesel Exhaust, Acute Vascular and Endothelial Responses",COMPLETED,NA,Healthy,OTHER: Forearm venous occlusion plethysmography study,INTERVENTIONAL,2011-04,2011-07,
NCT06643013,Targeting 18kDa Translocator Protein (TSPO) to Improve Brain Endothelial Cell Function in Cerebral Small Vessel Disease,RECRUITING,NA,Cerebral Small Vessel Disease,DRUG: XBD173,INTERVENTIONAL,2024-10,2028-04,
NCT04480892,Fibrinolytic Deficit in Patients With Acute PE,UNKNOWN,,Acute Pulmonary Embolism; Fibrinolytic Deficit,,OBSERVATIONAL,2020-08,2023-12,
NCT04180137,Management of Endothelial Dysfunction in Patients With Chronic Venous Insufficiency After Endovenous Surgical Procedure,COMPLETED,NA,Venous Insufficiency of Leg; Venous Insufficiency (Chronic)(Peripheral); Endothelial Dysfunction,PROCEDURE: Endovenous laser ablation of great saphenous vein (GSV) and microphlebectomy of varicose veins; DRUG: Pharmacotherapy,INTERVENTIONAL,2019-11-28,2020-12-31,
NCT01795248,The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Pregnancy-induced Diabetes,COMPLETED,PHASE4,Gestational Diabetes Mellitus,DRUG: Liraglutide; DRUG: Placebo,INTERVENTIONAL,2012-07,2019-09,
NCT00353834,The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes,COMPLETED,PHASE4,Type 2 Diabetes Mellitus,DRUG: Exenatide; DRUG: Glargine Insulin,INTERVENTIONAL,2006-08,2010-09,
NCT05328804,Herombopag + rhTPO in Severe Immune Thrombocytopenia,UNKNOWN,PHASE3,Immune Thrombocytopenia,DRUG: rhTPO; DRUG: Herombopag,INTERVENTIONAL,2022-01-01,2023-11-30,
NCT00141778,"Renin-angiotensin-aldosterone System (RAAS), Inflammation, and Post-Operative Atrial Fibrillation (AF)",COMPLETED,"PHASE2, PHASE3",Atrial Fibrillation,DRUG: Placebo; DRUG: Ramipril; DRUG: Spironolactone,INTERVENTIONAL,2005-04,2010-07,
NCT02264743,Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy,UNKNOWN,PHASE4,Venous Thrombosis; Insulin Resistance,DRUG: Femoston Conti; DRUG: EVOREL® CONTI,INTERVENTIONAL,2013-11,2014-11,
NCT05660798,Effects of Switching From Cigarettes to Tobacco Heating System on Coronary Atherosclerosis Progression,RECRUITING,NA,Coronary Artery Disease; Coronary Atherosclerosis; Nicotine Dependence,BEHAVIORAL: heated tobacco - lifestyle intervention,INTERVENTIONAL,2023-02-09,2025-12-31,
NCT00279045,Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide,COMPLETED,PHASE3,"Diabetes Mellitus, Type 2",DRUG: Rosiglitazone; DRUG: glyburide; DRUG: metformin,INTERVENTIONAL,2000-01-03,2006-06-01,
NCT01449110,Resveratrol-enriched Grape Extract (Stilvid) in Primary and Secondary Prevention of Cardiovascular Disease,COMPLETED,PHASE2,Cardiovascular Diseases,DIETARY_SUPPLEMENT: Placebo in primary cardiovascular prevention (PP); DIETARY_SUPPLEMENT: Placebo in secondary prevention; DIETARY_SUPPLEMENT: Grape extract in primary prevention (PP); DIETARY_SUPPLEMENT: Grape extract in SP; DIETARY_SUPPLEMENT: Resveratrol-enriched grape extract in PP; DIETARY_SUPPLEMENT: Resveratrol-enriched grape extract in SP,INTERVENTIONAL,2009-04,2010-10,
NCT05207774,Pre-operative Intranasal Oxytocin for Enhancing Bariatric-induced Diabetes Remission,UNKNOWN,NA,Obesity; Diabetes; Bariatric Surgery,DRUG: Oxytocin; DRUG: placebo,INTERVENTIONAL,2020-01-09,2023-08-30,
NCT02101814,Energy Balance and Inflammation in Obese Adults Bariatric Surgery Follow-up,UNKNOWN,NA,Obesity; Morbid Obesity; Metabolic Syndrome; Inflammation; Energy Balance,PROCEDURE: Roux-en-Y gastric bypass (bariatric surgery),INTERVENTIONAL,2013-03,2015-05,
NCT01317576,Optimizing the Beneficial Health Effects of Exercise for Diabetes: Focus on the Liver!,COMPLETED,NA,"Diabetes Mellitus, Type 2; Non-alcoholic Fatty Liver Disease; Obesity",BEHAVIORAL: Exercise intervention,INTERVENTIONAL,2011-03,2015-11,
NCT00934336,Importance in Type 1 Diabetes Patients of an Optimized Control of Post-Prandial Glycaemia on Oxidant Stress Prevention,COMPLETED,NA,Type 1 Diabetes,OTHER: Therapeutic and preventive strategies; OTHER: Therapeutic and preventive strategies,INTERVENTIONAL,2008-11,2011-04,
NCT07005193,Effects of LPG and Ventilation Interventions on Reducing HAP and Improving Cardiopulmonary Health,NOT_YET_RECRUITING,NA,Cardiopulmonary Function; Environmental Exposures,DEVICE: Using rang hood during cooking; BEHAVIORAL: Using liquefied gas for cooking,INTERVENTIONAL,2025-06-01,2029-06-30,
NCT01547104,"Effect of Linagliptin in Comparison With Glimepiride as Add on to Metformin on Postprandial Beta Cell Function, Postprandial Metabolism and Oxidative Stress in Patients With Type 2 Diabetes Mellitus",UNKNOWN,PHASE4,Diabetes Mellitus Type 2,DRUG: Linagliptin; DRUG: Glimepiride,INTERVENTIONAL,2012-04,2012-10,
NCT00808535,Cardiac Magnetic Resonance Imaging for Detecting Endothelial Dysfunction,UNKNOWN,,Endothelial Dysfunction; Myocardial Perfusion Abnormalities; Cardiac MRI Perfusion With Vasomotor Stress; Diabetes,PROCEDURE: Cardiac Perfusion MRI w Vasomotor Stress,OBSERVATIONAL,2009-02,2010-02,
NCT00000108,Effects of Training Intensity on the CHD Risk Factors in Postmenopausal Women,COMPLETED,NA,Cardiovascular Diseases; Coronary Disease,BEHAVIORAL: Exercise,INTERVENTIONAL,,,
NCT02394249,"SIT LESS 3: The Effect of Low Intensity Physical Activity on Insulin Sensitivity, Mood and Cognitive Performance",COMPLETED,NA,Overweight; Obesity,BEHAVIORAL: Physical activity regime,INTERVENTIONAL,2015-02,2015-09,
NCT02922348,Hormone Replacement for Premature Ovarian Insufficiency,WITHDRAWN,PHASE3,Primary Ovarian Insufficiency,DRUG: Hormone Replacement Therapy; DRUG: Combined Oral Contraceptives,INTERVENTIONAL,2016-03-01,2018-12-01,
NCT00775671,Comparative Effect of Nebivolol vs. Metoprolol on Insulin Sensitivity and Fibrinolytic Balance in Metabolic Syndrome,COMPLETED,PHASE4,Metabolic Syndrome,DRUG: placebo; DRUG: Nebivolol; DRUG: Metoprolol,INTERVENTIONAL,2008-10,2011-06,
NCT05627362,A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis.,ACTIVE_NOT_RECRUITING,PHASE2,Primary Sclerosing Cholangitis,DRUG: Elafibranor 80 mg; DRUG: Elafibranor 120 mg; DRUG: Placebo Matched to Elafibranor 80 mg; DRUG: Placebo Matched to Elafibranor 120 mg,INTERVENTIONAL,2022-12-29,2026-08-28,
NCT03434613,Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease,COMPLETED,PHASE4,Nonalcoholic Fatty Liver Disease; Dyslipidemias,DRUG: Rosuvastatin; DRUG: Rosuvastatin/ezetimibe combination,INTERVENTIONAL,2018-05-14,2019-09-11,
NCT03348163,(mo)BETTA Trial in Transwomen for Optimization of ART,TERMINATED,PHASE4,HIV Infections,DRUG: B/FTC/TAF; DRUG: Current ART,INTERVENTIONAL,2018-06-06,2020-12-15,
NCT00970970,Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease,COMPLETED,,Von Hippel-Lindau Disease; Hemangioblastoma; Renal Cell Carcinoma; Pheochromocytoma; Pancreatic Neuroendocrine Tumor,OTHER: 89Zr bevacizumab PET scan,OBSERVATIONAL,2009-09,2012-11,
NCT03585101,A Single-arm Evaluation of the Effect of HCV Treatment on Cardiovascular Disease Risk,WITHDRAWN,PHASE4,Hepatitis C,DRUG: Elbasvir/grazoprevir,INTERVENTIONAL,2018-08,2019-06,
NCT03557190,Endothelial Effects of VEGF Inhibition In Vivo in Man,COMPLETED,,Cardiovascular Diseases,,OBSERVATIONAL,2016-12-01,2018-07-01,
NCT00957762,Body Composition Assessment in Spinal Cord Injury,UNKNOWN,,Diabetes Mellitus; Body Composition; Tetraplegia; Paraplegia; Spinal Cord Injury,OTHER: Body composition,OBSERVATIONAL,2009-08,2012-09,
NCT01325454,Angiogenic Cytokines and Fibrinolytic Activity in Parapneumonic Effusions,UNKNOWN,,Pleural Effusion,DEVICE: pleural pigtail drainage,OBSERVATIONAL,2008-01,2011-06,
NCT05126251,Tangningtongluo Tablet for People With Prediabetes,UNKNOWN,PHASE2,Prediabetes,DRUG: Tangningtongluo tablet; BEHAVIORAL: lifestyle intervention,INTERVENTIONAL,2021-12-13,2022-12-31,
NCT05387577,Coagulation and Fibrinolysis of Estradiol in Transwomen,TERMINATED,EARLY_PHASE1,Transgenderism; Clotting Disorder,DRUG: Estradiol Tablets; DRUG: Transdermal patch; DRUG: Estradiol Tablets,INTERVENTIONAL,2021-12-07,2022-11-23,
NCT01509001,Study of Metabolic and Haemodynamic Effects of Metformin and Glimepiride in Patients With Type 2 Diabetes Mellitus,COMPLETED,PHASE4,Type 2 Diabetes,DRUG: Metformin; DRUG: Glimepiride,INTERVENTIONAL,2011-01,2012-01,
NCT01317108,Prognostic and Predictive Impact of uPA/PAI-1,COMPLETED,PHASE3,Breast Cancer,DRUG: CMF Chemotherapy,INTERVENTIONAL,1993-06,2008-12,
NCT01879033,Endothelial Function in Obese Adolescents,COMPLETED,NA,Insulin Resistance; Glucose Intolerance; Obesity; Atherosclerosis,"OTHER: Reactive hyperemia peripheral artery tonometry (Rh-PAT); OTHER: Blood levels for glucose, insulin, lipids and adipocytokines",INTERVENTIONAL,2011-03,2013-06,
NCT05595915,COMP-4 Supplementation and Brachial Artery FMD,ACTIVE_NOT_RECRUITING,"PHASE1, PHASE2",Aging; Endothelial Dysfunction; Senescence,DIETARY_SUPPLEMENT: COMP-4,INTERVENTIONAL,2023-06-01,2025-12-31,
NCT04926415,Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Obesity and Insulin Resistance,COMPLETED,NA,"Diabetes Mellitus, Type 2; Obesity",DEVICE: taVNS; DEVICE: Sham taVNS,INTERVENTIONAL,2021-06-14,2022-04-26,
NCT01211899,4G/5G Polymorphism of Plasminogen Activator Inhibitor-1 Gene and Disseminated Intravascular Coagulation in Severe Sepsis and Septic Shock,UNKNOWN,,Severe Sepsis,,OBSERVATIONAL,2010-09,2012-09,
NCT01654016,Study of Antiinflammatory Effects of Detralex (Daflon),COMPLETED,PHASE4,Chronic Venous Insufficiency,DRUG: Detralex,INTERVENTIONAL,2012-08,2019-05,
NCT06348771,Postprandial Inflammation and Nuts (PIN) in Older Adults,ACTIVE_NOT_RECRUITING,NA,Healthy Aging; Overweight and Obesity,BEHAVIORAL: monounsaturated fatty acids (MUFA) peanut meal,INTERVENTIONAL,2024-03-25,2025-01-06,
NCT05274971,Diet and Exercise on Ambulatory Blood Pressure,COMPLETED,NA,Prehypertension,OTHER: Active dietary management and aerobic exercise training.,INTERVENTIONAL,2022-05-15,2023-11-01,
NCT02567903,Tourniquet Study: A Clinical Trial Into the Effect of Tourniquet Use on the Coagulation System,COMPLETED,NA,Venous Thrombosis,DEVICE: Thigh Tourniquet; PROCEDURE: Knee arthroscopy,INTERVENTIONAL,2015-09,2019-06,
NCT03580057,Effect of Weight Loss and Lactation (the EVA-trial),COMPLETED,NA,Cardiovascular Risk Factor,BEHAVIORAL: Breastfeeding promotion intervention; BEHAVIORAL: Diet and weight loss intervention,INTERVENTIONAL,2018-01-30,2023-12-15,
NCT02648555,A Lifestyle Intervention to Improve in Vitro Fertilization Results,UNKNOWN,NA,Sterility; Placenta; Implantation; Risk Reduction Behavior; Lifestyle; Neonatal Hypoglycemia,BEHAVIORAL: Daily walking; BEHAVIORAL: Dietary recommendations,INTERVENTIONAL,2016-05,2018-05,
NCT02613741,Metabolism of Fibrinogen and Apolipoprotein B-100 in Childhood Obesity and Cardiovascular Disease,COMPLETED,NA,Obesity; Cardiovascular Disease,OTHER: Lifestyle-based physical activity,INTERVENTIONAL,2001-01,2004-01,
NCT02158845,Levonorgestrel-releasing Intrauterine System in Patients With Endometriosis,COMPLETED,PHASE4,Endometriosis,DRUG: LNG-IUS: levonorgestrel intrauterine system; DRUG: GnRHa: leuprolide,INTERVENTIONAL,2010-02,2012-09,
NCT01215370,Pea Protein and Postprandial Response (PEA),COMPLETED,NA,Metabolic Syndrome,OTHER: High-fat shake with Pea protein; OTHER: High-fat shake with Pea protein hydrolysate; OTHER: High-fat shake - Control; OTHER: High-fat shake with Gluten protein; OTHER: High-fat shake with Gluten protein hydrolysate,INTERVENTIONAL,2010-09,2011-01,
NCT01208012,Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in Type 2 Diabetes Mellitus,COMPLETED,PHASE4,"Diabetes Mellitus, Type 2",DRUG: Victoza®,INTERVENTIONAL,2010-04,2010-11,
NCT01527253,Effect of a Synergistic Food Basket on Metabolic Syndrome Risk,COMPLETED,NA,Metabolic Syndrome; Insulin Resistance,OTHER: Synergistic food basket,INTERVENTIONAL,2011-09,2012-05,
NCT04013568,Exercise Post-Diagnosis of Breast Cancer,ACTIVE_NOT_RECRUITING,NA,Breast Cancer,OTHER: Exercise,INTERVENTIONAL,2019-08-28,2026-09-01,
NCT02236533,Healthy Effects of an Innovative Probiotic Pasta,COMPLETED,NA,OBESITY; INFLAMMATION; DYSLIPIDEMIA; CONSTIPATION,DIETARY_SUPPLEMENT: whole grain pasta,INTERVENTIONAL,2014-03,2014-09,
NCT00331487,Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia,COMPLETED,PHASE3,Diabetes Mellitus,DRUG: Pioglitazone; DRUG: Rosiglitazone,INTERVENTIONAL,2000-09,2004-03,
NCT02348814,Development of a Novel Biomarker for Liver Fibrosis,COMPLETED,,Liver Fibrosis,,OBSERVATIONAL,2015-05,2019-01-26,
NCT01161901,Impact of Inflammation Biomarkers on the Acute Respiratory Distress Syndrome (ARDS) Definition,COMPLETED,,Acute Respiratory Distress Syndrome,PROCEDURE: blood sample,OBSERVATIONAL,2010-06,2011-11,
NCT02526628,Thrombosis and Neurocognition in Klinefelter Syndrome,COMPLETED,,Klinefelter Syndrome; Thrombosis,,OBSERVATIONAL,2015-09,2019-08-21,
NCT00770445,Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.,COMPLETED,PHASE4,Diabetes Mellitus,DRUG: Pioglitazone and insulin; DRUG: Pioglitazone and metformin and insulin; DRUG: Metformin and insulin,INTERVENTIONAL,2008-05,2010-07,
NCT00134199,"A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects",COMPLETED,"PHASE2, PHASE3",Obesity,"DRUG: CP-945,598; DRUG: sibutramine",INTERVENTIONAL,2005-03,,
NCT04804124,Sleep Duration and Cardiovascular Health,RECRUITING,NA,Sleep; Cardiovascular Risk Factor,BEHAVIORAL: Regularized Sleep Schedule,INTERVENTIONAL,2021-06-09,2026-03-15,
NCT01995240,Functional Magnetic Resonance Imaging of Pancreatic Cancer: a Feasibility and Reproducibility Study,COMPLETED,NA,Pancreatic Cancer,DRUG: Gadobutrol,INTERVENTIONAL,2013-04,2017-02,
NCT03300388,"Obesity, Inflammation and Aging: Effects of Physical Exercise and Omega-3 Fatty Acids.",COMPLETED,NA,Obesity; Aging; Inflammation,DIETARY_SUPPLEMENT: Omega-3 (DHA-rich dietary supplement); DIETARY_SUPPLEMENT: Placebo (olive oil); OTHER: Resistance training,INTERVENTIONAL,2017-08-21,2019-06-13,
NCT06355310,Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease,RECRUITING,PHASE2,Non-Alcoholic Fatty Liver Disease,DRUG: Empagliflozin 10 MG; DRUG: Placebo Oral Tablet,INTERVENTIONAL,2025-01-27,2028-01-01,
NCT05009862,"The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease",RECRUITING,PHASE4,Peripheral Arterial Disease,DRUG: Rivaroxaban 2.5 Mg Oral Tablet; DRUG: Placebo; DRUG: Aspirin 81Mg Ec Tab,INTERVENTIONAL,2022-04-19,2025-12-31,
NCT00512369,Effects of PA-1 Transcriptional Regulation on Monocyte Function,TERMINATED,,Atherosclerosis,,OBSERVATIONAL,2006-03,,
NCT02400151,Vascular and Metabolic Effects of Vitamin D Supplementation Associated With Lifestyle Management in Obese Adolescents,COMPLETED,PHASE4,Obesity,DRUG: Vitamin D supplementation; DRUG: Placebo; OTHER: 3 months lifestyle and dietary management; OTHER: Normal control,INTERVENTIONAL,2015-03-30,2016-06-24,
NCT02257450,Primary Aldosteronism in Malaysia: A Nationwide Multicentre Study,UNKNOWN,,Primary Aldosteronism,,OBSERVATIONAL,2014-10,2017-06,
NCT02058823,Intermittent Hypoxia 2: Cardiovascular and Metabolism,TERMINATED,PHASE4,Hypoxia; Sleep Apnea; Obstructive Sleep Apnea,DRUG: Placebo; DRUG: Placebo; DRUG: Valsartan; DRUG: Amlodipine,INTERVENTIONAL,2013-08-07,2014-07-17,
NCT01687959,Timing of Laparoscopic Cholecystectomy After Endoscopic Retrograde Cholangiography for Acute Biliary Pancreatitis,UNKNOWN,EARLY_PHASE1,Cholelithiasis Associated With Common Bile Duct Stones,OTHER: tissue sampling from peritoneum of the gallbladder,INTERVENTIONAL,2012-09,2015-06,
NCT01913470,Study of Losartan in the Treatment of NAFLD in Children,COMPLETED,PHASE2,NAFLD,DRUG: Losartan,INTERVENTIONAL,2013-07,2015-12,
NCT02923765,"Stepper Aerobic Training on Fitness, Disability, Inflammation and Thrombosis in Stroke Patients",COMPLETED,NA,Ischemic Stroke,OTHER: Aerobic training by a stepper,INTERVENTIONAL,2017-08-01,2020-02-26,
NCT01456208,Genetic Mechanisms in Human Hypertension,TERMINATED,,Hypertension,DRUG: Para-aminohippuric Acid; DRUG: Angiotensin II; DRUG: Norepinephrine,OBSERVATIONAL,1999-10,2020-06,
NCT03394664,"FB4 (Framingham, Boston, Bloomington, Birmingham, and Baylor)",TERMINATED,NA,Obesity,BEHAVIORAL: Feeding Study,INTERVENTIONAL,2018-05-09,2020-05-03,
NCT02878421,Vascular EffectS of regUlar Cigarettes Versus electronIc Cigarette USe,COMPLETED,NA,Vascular Diseases,DEVICE: electronic cigarette + 16mg nicotine & flavor; OTHER: electronic cigarette + 0mg nicotine & flavor; OTHER: Tobacco cigarette,INTERVENTIONAL,2016-08-18,2018-07-31,
NCT02231021,The Practical Evidence of Antidiabetic Combination Therapy in Korea,COMPLETED,PHASE4,Type 2 Diabetes Mellitus,DRUG: alogliptin; DRUG: Pioglitazone; DRUG: alogliptin + pioglitazone,INTERVENTIONAL,2014-09,2018-10-22,
NCT04634799,Study to AntagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19,SUSPENDED,"PHASE1, PHASE2",Covid19,DRUG: TM5614; OTHER: Placebo,INTERVENTIONAL,2021-01-08,2025-04-23,
NCT00778622,Body Weight Effects on Glucophage's Efficacy in Chinese Diagnosed T2DM Patients,COMPLETED,PHASE4,Type 2 Diabetes Mellitus,DRUG: Metformin XR,INTERVENTIONAL,2009-11,2011-03,
NCT07088705,Subthreshold Micropulse Laser Therapy (SML) in Retinitis Pigmentosa,ENROLLING_BY_INVITATION,NA,Retinitis Pigmentosa (RP),DEVICE: SML 577 nm; DEVICE: SML 810 nm; OTHER: Sham SML,INTERVENTIONAL,2024-09-01,2026-08,
NCT01999088,Health Benefits of Functional Meat (With n-3 Fatty Acids and Rosemary Extract) on Low Risk for Cardiovascular Disease People,COMPLETED,PHASE4,Low Risk for Cardiovascular Disease,OTHER: Functional Meet; OTHER: Control Meat,INTERVENTIONAL,2009-05,2010-06,
NCT05994742,An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM,RECRUITING,PHASE3,Severe Acute Malnutrition; HIV; Comorbidities and Coexisting Conditions; Child Malnutrition,DRUG: Rifampicin; DRUG: Azithromycin; DRUG: Isoniazid; DRUG: Pyridoxine Hydrochloride; BEHAVIORAL: The Friendship Bench; BEHAVIORAL: Care for Child Development; BEHAVIORAL: Educational and behaviour-change modules; DIETARY_SUPPLEMENT: Reformulated Ready to Use Therapeutic Food; OTHER: Standard Care,INTERVENTIONAL,2024-07-15,2026-07-15,
NCT02369536,Efficacy of a Natural Components Mixture in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD),COMPLETED,NA,Non-alcoholic Fatty Liver Disease,DIETARY_SUPPLEMENT: nutraceutical mixture; DIETARY_SUPPLEMENT: placebo,INTERVENTIONAL,2015-08-18,2016-09-15,
NCT01748253,ARB and CCB Longest Combination Treatment on Ambulatory and Home BP in Hypertension With Atrial Fibrillation -Multicenter Study on Time of Dosing (ACROBAT),UNKNOWN,NA,Hypertension and Atrial Fibrillation,DRUG: Telmisartan-amlodipine tablet administration group (morning); DRUG: Telmisartan-amlodipine tablet administration group (bedtime),INTERVENTIONAL,2012-11,2013-10,
NCT04780568,Osimertinib and Tegavivint As First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung Cancer,RECRUITING,PHASE1,Metastatic Lung Non-Small Cell Carcinoma; Stage IV Lung Cancer AJCC V8; Stage IVA Lung Cancer AJCC V8; Stage IVB Lung Cancer AJCC V8,DRUG: Osimertinib; DRUG: Tegavivint,INTERVENTIONAL,2022-01-18,2025-07-31,
NCT02423642,Immunomodulation Effect of Regional Citrate Anticoagulation in Acute Kidney Injury Requiring Continuous Renal Replacement Therapy,COMPLETED,NA,Acute Kidney Injury,PROCEDURE: Continuous renal replacement therapy with regional citrate anticoagulation; PROCEDURE: Continuous renal replacement therapy with no anticoagulation or heparin,INTERVENTIONAL,2013-07,2014-11,
NCT05686954,Cottonseed Oil Dose Response,RECRUITING,NA,"Dyslipidemias; Overweight and Obesity; Nutrition, Healthy",OTHER: CSO LOW; OTHER: CSO MID; OTHER: CSO HIGH; OTHER: CONTROL,INTERVENTIONAL,2023-03-01,2026-05,
NCT03518294,NASH Fitness Intervention in Thrombosis Trial (NASHFit),COMPLETED,NA,Liver Diseases; Blood Disorder; Digestive System Disease,BEHAVIORAL: Aerobic Exercise,INTERVENTIONAL,2018-06-01,2021-03-24,
NCT07123181,Oregano and Basil Leaves and Coronary Artery Disease,NOT_YET_RECRUITING,NA,Acute Coronary Syndromes; Unstable Angina (UA),OTHER: Control (Standard treatment); OTHER: Higher polyphenol intake by consumption of oregano and basil,INTERVENTIONAL,2025-09-01,2026-03-17,
NCT03050671,Effects of External Leg Compression Devices on Healing and Blood Clotting,ENROLLING_BY_INVITATION,NA,Venous Stasis; Deep Venous Thrombosis; Healing Wound,"DEVICE: Intermittent Pneumatic Compression, Rapid; DEVICE: Intermittent Pneumatic Compression, Slow",INTERVENTIONAL,2017-01-18,2024-12-01,
NCT01317264,β-Glucans and the Metabolic Syndrome - a Human Intervention Study Under BEST,COMPLETED,NA,Healthy,OTHER: no β-glucan; OTHER: oat β-glucan; OTHER: barley β-glucan; OTHER: mutant-barley β-glucan,INTERVENTIONAL,2009-11,2010-10,
NCT00681564,Periodontal Infection and Endothelial Dysfunction,COMPLETED,PHASE3,Periodontitis,PROCEDURE: One-Stage Full-Mouth Disinfection; PROCEDURE: Periodontal care,INTERVENTIONAL,2008-05,2011-03,
NCT03883607,"Elafibranor, PK and Safety in Children and Adolescents 8 to 17 Years of Age With Non Alcoholic Steatohepatitis (NASH)",TERMINATED,PHASE2,Non Alcoholic Steatohepatitis,DRUG: Elafibranor 80mg; DRUG: Elafibranor 120mg,INTERVENTIONAL,2019-06-25,2020-06-16,
NCT06479421,A Clinical Study for Developing Artificial Intelligence(AI)-Based Clustering Model for Personalized Medicine in Acute Respiratory Failure,RECRUITING,,Acute Respiratory Failure,,OBSERVATIONAL,2023-08-14,2025-02-28,
NCT02354794,Effect of Arginine Supplementation in the Metabolic Syndrome,COMPLETED,NA,Overweight; Hypertriglyceridemic Waist,DIETARY_SUPPLEMENT: One form of arginine; DIETARY_SUPPLEMENT: placebo,INTERVENTIONAL,2014-02,2014-05,
NCT00988078,Effects of Metformin and Oral Hormonal Contraceptive in Adolescents With Polycystic Ovary Syndrome,UNKNOWN,NA,Polycystic Ovary Syndrome,DRUG: Placebo; DRUG: Metformin,INTERVENTIONAL,2011-07,2013-10,
NCT06680635,Effect of Citrus Flavonoids on Obesity.,COMPLETED,NA,Obesity Adult Onset; Diabetes Mellitus Type 2,DIETARY_SUPPLEMENT: Flavonoid-enriched juice and a low-calorie diet; DIETARY_SUPPLEMENT: Food supplement: placebo juice and a low calorie diet,INTERVENTIONAL,2022-01-01,2024-12-31,
NCT04230655,"Weight Loss in Adults With Obesity Using a Combination of Low Energy Diet, Group Treatment and Intragastric Balloon",UNKNOWN,NA,Obesity; Weight Loss; Non-Alcoholic Fatty Liver Disease,DIETARY_SUPPLEMENT: Low energy diet using meal replacements; BEHAVIORAL: CBT-based group treatment; DEVICE: Intragastric balloon,INTERVENTIONAL,2019-12-10,2022-12,
NCT04703036,"Glutathione, Oxidative Stress and Mitochondrial Function in COVID-19",TERMINATED,EARLY_PHASE1,Covid19,DIETARY_SUPPLEMENT: Glycine; DIETARY_SUPPLEMENT: N-acetylcysteine; DIETARY_SUPPLEMENT: Alanine,INTERVENTIONAL,2021-01-11,2023-03-31,
NCT02361944,Risk of Oxygen During Cardiac Surgery Trial,COMPLETED,"PHASE2, PHASE3",Cardiac Surgery,DRUG: Oxygen - normoxia; DRUG: Oxygen - hyperoxia,INTERVENTIONAL,2016-04-05,2020-10-08,
NCT04305171,Effect of Non-surgical Periodontal Treatment on Cardiovascular Risk Markers,COMPLETED,,Coronary Heart Disease; Periodontitis,PROCEDURE: non-surgical periodontal treatment,OBSERVATIONAL,2018-04-06,2020-01-31,
NCT06296823,Biomarkers for Peripheral Circadian Clocks in Humans,RECRUITING,NA,Circadian Rhythms,BEHAVIORAL: Simulated jetlag protocol,INTERVENTIONAL,2023-09-01,2027-08-31,
NCT02250989,The Influence of Glycaemia and Insulinemia on Vasomotor Endothelial Function After Myocardial Infarction,UNKNOWN,,Myocardial Infarction,,OBSERVATIONAL,2014-07,2016-02,
NCT04557540,Weight Loss Interventions for Black Adults of Faith,COMPLETED,NA,Obesity-Related Malignant Neoplasm,BEHAVIORAL: Lifestyle Therapy; OTHER: Quality-of-Life Assessment; OTHER: Questionnaire Administration; OTHER: Short-Term Fasting,INTERVENTIONAL,2021-09-25,2022-12-07,
NCT05062707,Early Ageing During Therapy in AYA Cancer Patients,RECRUITING,,Cancer; Leukemia; Hodgkin Lymphoma; Testicular Cancer; Osteosarcoma; Ewing Sarcoma; Breast Cancer; Cervical Cancer,PROCEDURE: Blood sampling,OBSERVATIONAL,2022-02-10,2025-07,
NCT02760914,Adipose Tissue and Inflammation in Coronary Heart Disease,ACTIVE_NOT_RECRUITING,,Coronary Heart Disease,,OBSERVATIONAL,2016-06,2029-12,
NCT02957630,"""E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study""",COMPLETED,"PHASE1, PHASE2",Contraception; Liver Metabolism; Hemostasis Parameter,DRUG: 15 mg E4/3 mg DRSP; DRUG: 30 mcg EE/150 mcg LNG; DRUG: 20 mcg EE/3 mg DRSP,INTERVENTIONAL,2016-09,2017-10-09,
NCT04997928,PAI-1 Levels and Predicting Covid-19 Patients' Prognosis,UNKNOWN,,Covid-19 Positivity Confirmed With PCR Positivity in the Nasopharyngeal Swab; Symptomatic Covid -19 Positive Patients Who Require Hospitalization; Patients Who Did Not Vaccinate Against Covid-19; Patients Among 20 to 90 Years of Age; Healthy Control Patients of the Same Age,OTHER: Serum PAI-1 alpha analysis.,OBSERVATIONAL,2021-01-18,2021-08-30,
NCT01371305,STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF),COMPLETED,PHASE2,Idiopathic Pulmonary Fibrosis (IPF),DRUG: BG00011; DRUG: Placebo,INTERVENTIONAL,2012-07-16,2017-03-31,
NCT02803554,Young Donor Plasma Transfusion and Age-Related Biomarkers,COMPLETED,NA,Aging,OTHER: Plasma,INTERVENTIONAL,2016-06,2018-01-15,
NCT06901739,Therapeutic Potential of a Synbiotic to Improve Mental Health in Subjects With Obesity.,RECRUITING,NA,Obese Patients (BMI ≥ 30 kg/m²); Anxiety; Depressive Disorder,DIETARY_SUPPLEMENT: Synbiotic; DIETARY_SUPPLEMENT: Placebo,INTERVENTIONAL,2025-04-15,2027-04-30,
NCT01405456,Eplerenone in HIV Associated Abdominal Fat Accumulation,COMPLETED,NA,HIV,DRUG: Eplerenone and lifestyle; OTHER: placebo and lifestyle,INTERVENTIONAL,2012-01,2017-05-03,
NCT01524653,Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE),COMPLETED,PHASE2,Venous Thromboembolism; Deep Vein Thrombosis; Neoplasms,DRUG: Rosuvastatin; DRUG: Placebo,INTERVENTIONAL,2012-03,2016-07-01,
NCT01796561,The Effect of Olive Leaf Extract on Blood Pressure in Overweight Prehypertensives,COMPLETED,NA,Hypertension,DIETARY_SUPPLEMENT: Olive leaf extract liquid,INTERVENTIONAL,2013-02,2013-10,
NCT04050592,Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life,UNKNOWN,PHASE4,Menopause; Atherosclerosis; Cardiovascular Diseases; Estrogen Replacement Therapy,DRUG: Estradiol; OTHER: Placebo,INTERVENTIONAL,2020-02-19,2022-12,
NCT00174902,The Effect of Beta-Blockers and Aspirin on Hemostasis and Endothelial Function After Acute Mental Stress,UNKNOWN,"PHASE1, PHASE2","Arteriosclerosis; Stress, Psychological","DRUG: inderal (drug), acetylsalicylic acid (drug)",INTERVENTIONAL,2003-10,,
NCT05862805,"PAI-1, tPA, TFPI and HEECs in Uterine Hemostasis",RECRUITING,"PHASE1, PHASE2","Menstrual Bleeding, Heavy",PROCEDURE: Sample Collection and Endometrial Biopsy,INTERVENTIONAL,2023-07-12,2025-07,
NCT00214825,Aldosterone and Vascular Disease in Diabetes Mellitus,COMPLETED,NA,Diabetes Mellitus; Endothelial Dysfunction; Albuminuria,DRUG: eplerenone; DRUG: Hydrochlorothiazide,INTERVENTIONAL,2003-08,2006-03,
NCT06279780,"Gut Microbiota, Mitochondrial Function and Metabolic Health in Obesity",COMPLETED,NA,Obesity Adult Onset,DIETARY_SUPPLEMENT: very low-calorie diet,INTERVENTIONAL,2019-01-01,2023-12-31,
NCT01071096,Calcitonin Gene-related Peptide Levels in Chronic Migraine,COMPLETED,PHASE4,Chronic Migraine,DRUG: OnabotulinumtoxinA; DRUG: Saline,INTERVENTIONAL,2010-06,2011-06,
NCT02073929,LIPT - Liraglutide in Polycystic Ovary Syndrome,COMPLETED,PHASE4,Polycystic Ovary Syndrome; Cardiovascular Disease,DRUG: Liraglutide for 26 weeks; DRUG: placebo,INTERVENTIONAL,2014-03,2015-12,
NCT01222052,6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer Patients,UNKNOWN,PHASE3,Breast Cancer,"DRUG: 5-Fluorouracil, Epirubicin, Cyclophosphamide, Docetaxel",INTERVENTIONAL,2002-01,2009-02,
NCT01087411,Intervention Study to Prevent Obesity in Sedentary 8 Year Old Swedish Children,WITHDRAWN,NA,Cardiovascular Risk Factors; Metabolic Risk Factors; Sedentary Lifestyle; Overweight,BEHAVIORAL: Motivational Interviewing; BEHAVIORAL: Physical activity; DIETARY_SUPPLEMENT: Supplementation with fish liver oli capsules; DIETARY_SUPPLEMENT: Placebo oil capsules,INTERVENTIONAL,2008-10,2012-06,
NCT02352740,Characterization of the Metabolic Fate of an Oral Arginine Form,COMPLETED,NA,Overweight; Hypertriglyceridemic Waist,DIETARY_SUPPLEMENT: A form Arginine; DIETARY_SUPPLEMENT: B form Arginine,INTERVENTIONAL,2013-03,2013-05,
NCT00139477,Study of Serum Markers for Cardiovascular Risk in Obese Youth and Impact of Lifestyle and Medication Intervention,COMPLETED,NA,Obesity,DRUG: Metformin; BEHAVIORAL: Dietary modification with caloric restriction; BEHAVIORAL: Establishment of exercise protocol,INTERVENTIONAL,2003-11,2009-05,
NCT00465426,HIV and Cardiovascular Risk,COMPLETED,,HIV Infections; Cardiovascular Disease,,OBSERVATIONAL,2007-04,2011-11,
NCT01592825,PiA: Prognosis Used Every Day for Patients With Operable Breast Cancer - Comparison of Invasion Factors uPA/PAI-1 With Other Prognostic Factors,UNKNOWN,,Breast Cancer,,OBSERVATIONAL,2009-09,2011-05,
NCT01138774,Effects of Lipoic Acid and Eicosapentaenoic Acid (EPA) in Human Obesity,COMPLETED,NA,Obesity; Body Fat; Insulin Resistance,DIETARY_SUPPLEMENT: Double blind dietary intervention with EPA and lipoic acid,INTERVENTIONAL,2010-01,2011-12,
NCT05464186,Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children,RECRUITING,NA,Obesity; Diabetes; Cardiovascular Diseases,BEHAVIORAL: Whole milk; BEHAVIORAL: Nonfat milk,INTERVENTIONAL,2022-12-28,2025-10,
NCT04453527,The CASCADE Study - Measures of Complement Activation and Inflammation in Patients With Covid-19,COMPLETED,,Coronavirus,,OBSERVATIONAL,2020-05-28,2021-05-30,
NCT04643548,WHO Covid 19 - Neurological Abnormalities in SARS-CoV-2 ICU Patients,UNKNOWN,,SARS-CoV-2 Infection; Intensive Care Unit Patient; Neurological Abnormality; Delirium; Encephalopathy,,OBSERVATIONAL,2020-10-13,2021-06-13,
NCT00515021,Diurnal Variation of Plasminogen Activator Inhibitor-1,COMPLETED,PHASE4,Metabolic Syndrome X,DRUG: Eplerenone (Morning); DRUG: Eplerenone (Night-time),INTERVENTIONAL,2007-04,2010-04,
NCT06092060,"The Effect of a Multistrain Probiotic on Metformin Tolerance and Efficacy With Microbiota and Stool Metabolome in Insulin-resistant Women - a 12-week Randomized, Placebo-controlled, Double-blind Study",COMPLETED,NA,Insulin Resistance,DIETARY_SUPPLEMENT: the group GS (probiotic); DIETARY_SUPPLEMENT: the group GP (placebo),INTERVENTIONAL,2021-04-01,2022-02-01,
NCT05231642,Individualised Postprandial Glucose Responses in Type 1 Diabetes,COMPLETED,NA,Type 1 Diabetes; Diabetes Complications; Postprandial Hyperglycemia,OTHER: Nutritional Interventional,INTERVENTIONAL,2021-11-30,2022-12-10,
NCT01206712,Beta Cell Relieving and Cardiovascular Protective Effects of LANTUS Treatment in Type 2 Diabetes Patients,COMPLETED,,"Diabetes Mellitus, Type 2",,OBSERVATIONAL,2009-11,2010-07,
NCT00743301,"The Effect of Palm Olein, Olive Oil and Lard and on Risk Markers of Cardiovascular Disease",UNKNOWN,NA,Cardiovascular Disease; Metabolic Syndrome,OTHER: Palm olein vs olive oil and lard,INTERVENTIONAL,2008-08,2009-02,
NCT04375046,Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications Better Than Recombinant Human ACE2,UNKNOWN,PHASE1,COVID-19,DRUG: Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2),INTERVENTIONAL,2021-07,2021-08,
NCT03039205,Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor,COMPLETED,PHASE2,Platelet Aggregation; Adenosine; Coronary Artery Disease; Kidney Dysfunction; Antiplatelet Therapy,DRUG: Clopidogrel; DRUG: Ticagrelor,INTERVENTIONAL,2017-11-07,2019-12-19,
NCT01591096,Thrombolysis in Pediatric Stroke (TIPS),TERMINATED,PHASE1,Stroke,DRUG: Tissue plasminogen activator (Activase®),INTERVENTIONAL,2012-10,2013-12,
NCT06247202,Effect of Smart Phone Health Education on Overweight and Obese Schoolchildren's Dietary Habits and Body Composition,COMPLETED,NA,Childhood Obesity,OTHER: Smart Phone Education (mhealth); OTHER: Paper Education (conventional),INTERVENTIONAL,2023-12-01,2024-03-10,
NCT04311073,Prophylactic Tranexamic Acid During Minimally Invasive Myomectomies,UNKNOWN,PHASE3,Fibroid Uterus; Abnormal Uterine Bleeding; Myoma;Uterus,DRUG: Tranexamic Acid; DRUG: Placebos,INTERVENTIONAL,2020-06-20,2024-07-30,
NCT01644994,Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma,COMPLETED,"PHASE1, PHASE2",Malignant Pleural Mesothelioma,COMBINATION_PRODUCT: intracavitary cisplatin-fibrin,INTERVENTIONAL,2012-11,2019-12,
NCT01813929,Effect of Metformin on Vascular and Mitochondrial Function in Type 1 Diabetes,COMPLETED,PHASE4,Type 1 Diabetes,DRUG: Metformin; DRUG: Placebo,INTERVENTIONAL,2011-06,2017-03-24,
NCT00328627,Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.,COMPLETED,PHASE3,Type 2 Diabetes Mellitus,DRUG: Alogliptin; DRUG: Alogliptin placebo; DRUG: Pioglitazone; DRUG: Pioglitazone placebo,INTERVENTIONAL,2006-05,2008-03,
NCT00558883,AI(I)DA Acarbose and the Subclinical Inflammation,COMPLETED,PHASE3,Type 2 Diabetes Mellitus; Subclinical Inflammation,DRUG: acarbose,INTERVENTIONAL,2005-01,,
NCT01883466,Health Effects of Biodiesel Exhaust Exposure,COMPLETED,NA,Vascular Endothelium,OTHER: Forearm venous occlusion plethysmography study,INTERVENTIONAL,2012-09,2013-01,
NCT01723930,Transpulmonary Gradient After Cardiac Surgery Under Cardiopulmonary Bypass,UNKNOWN,,Acute Respiratory Distress Syndrome After Cardiac Surgery Under Cardiopulmonary Bypass,,OBSERVATIONAL,,,
NCT01140542,"Efficacy of 500µg Roflumilast Once Daily Versus Placebo Over 12 Weeks in Patients With Diabetes Mellitus Type 2. A Double Blind, Parallel Group, Proof of Concept Clinical Study",COMPLETED,PHASE2,Diabetes Mellitus Type 2,DRUG: Roflumilast,INTERVENTIONAL,2006-08,2007-11,
NCT01489202,Effects of DES Platforms on Markers of Endothelial Damage and Inflammation,UNKNOWN,PHASE4,Coronary Artery Disease,DEVICE: platinum chromium everolimus-eluting stent; DEVICE: cobalt chromium everolimus-eluting stent,INTERVENTIONAL,2014-09,2015-12,
NCT00642434,Comparison of Blood Pressure Medications on Metabolism,COMPLETED,PHASE4,Diabetes,DRUG: carvedilol; DRUG: metoprolol,INTERVENTIONAL,2004-01,2008-06,
NCT02239744,Intervention Study on the Health Impact of Air Filters in Chinese Adults,COMPLETED,NA,Inflammation; Coagulation; Blood Pressure; Pulmonary Function,BEHAVIORAL: Air purifiers,INTERVENTIONAL,2014-09,2014-11,
NCT01596309,Cocoa Extract-enriched Meals and Cardiovascular Risk in Older Population,COMPLETED,NA,Cardiovascular Risk Factors,DIETARY_SUPPLEMENT: Cocoa extract,INTERVENTIONAL,2012-01,2012-07,
NCT03611582,Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Program,COMPLETED,PHASE3,Overweight; Obesity,DRUG: Semaglutide; DRUG: Placebo (semaglutide),INTERVENTIONAL,2018-08-01,2020-03-18,
NCT05417191,Effect of Differently Fed Farmed Gilthead Sea Bream Consumption,COMPLETED,NA,Cardiometabolic Health,BEHAVIORAL: Conventional fish; BEHAVIORAL: Enriched fish,INTERVENTIONAL,2012-12-01,2013-11-30,
NCT00816218,Molecular Mechanisms of Type 2 Diabetes Mellitus,COMPLETED,PHASE4,Type 2 Diabetes Mellitus,DRUG: Pioglitazone,INTERVENTIONAL,2003-03,2006-07,
NCT05192603,Comparison Between Low FODMAP and SSRD in IBS,ENROLLING_BY_INVITATION,NA,IBS - Irritable Bowel Syndrome,DIETARY_SUPPLEMENT: low FODMAP or SSRD,INTERVENTIONAL,2022-03-01,2024-02-13,
NCT07097974,Evaluation of the Efficacy of the Composite WM Formula in Body Weight Change,NOT_YET_RECRUITING,NA,Obesity,DIETARY_SUPPLEMENT: WM formula liquid drink; DIETARY_SUPPLEMENT: Placebo,INTERVENTIONAL,2025-08-31,2025-11-30,
NCT02768987,Bright 1 Bodies Weight Management Program,COMPLETED,NA,"Diabetes Mellitus, Type 1",BEHAVIORAL: Bright 1 Bodies,INTERVENTIONAL,2016-07,2017-10-31,
NCT00007410,Genetic Architecture of Plasma T-PA and PAI-1,COMPLETED,,Cardiovascular Diseases; Heart Diseases; Thrombosis; Atherosclerosis,,OBSERVATIONAL,2000-09,2006-07,
NCT00296153,Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment,COMPLETED,PHASE4,Human Immunodeficiency Virus; Ischemic Heart Disease,DRUG: Omega-3-acid ethyl esters 90,INTERVENTIONAL,2006-02,2006-11,
NCT03807570,Efficacy and Safety Morus Alba L. Extract on Improvement of Blood Flow,UNKNOWN,NA,Blood Flow,DIETARY_SUPPLEMENT: Morus Alba L. Extract; DIETARY_SUPPLEMENT: Placebo,INTERVENTIONAL,2018-11-12,2021-01-30,
NCT04915456,Effect of Postoperative Additive Systemic Steroids in CRSwNP,COMPLETED,PHASE4,"Sinusitis, Chronic",DRUG: Systemic Steroid (Prednisolone); OTHER: Placebo,INTERVENTIONAL,2005-01-18,2020-04,
NCT05137613,One and Two-visit Root Canal Retreatment,COMPLETED,NA,Root Canal Infection,OTHER: One visit root canal retreatment; OTHER: Two visit root canal retreatment,INTERVENTIONAL,2018-07-01,2021-05-01,
NCT01572818,Effects of Phlebotomy on Insulin Sensitivity in Insulin Resistance-associated Hepatic Iron Overload Patients,COMPLETED,NA,Insulin Resistance; Iron Overload,PROCEDURE: phlebotomy; BEHAVIORAL: dietary and lifestyle counseling,INTERVENTIONAL,2010-10,2015-10,
NCT07016451,Efficacy of Low-Intensity Shockwave Therapy in Treating Radiation Cystitis,ENROLLING_BY_INVITATION,EARLY_PHASE1,Radiation Cystitis,PROCEDURE: Li-ESWT; DRUG: Medication,INTERVENTIONAL,2024-04-02,2026-05-30,
NCT02187120,Pre-hospital Anti-fibrinolytics for Traumatic Coagulopathy and Haemorrhage (The PATCH Study),COMPLETED,PHASE3,Wounds and Injuries; Acute Coagulopathy,DRUG: Tranexamic Acid; DRUG: Placebo,INTERVENTIONAL,2014-07-28,2022-05-09,
NCT06880107,Genetic Variants of Annexin A2 and Cryptogenic Stroke,NOT_YET_RECRUITING,NA,Annexin A2; Stroke; Genetic Variants of Host; Fibrinolysis,BIOLOGICAL: blood withdrawal,INTERVENTIONAL,2025-07,2027-04,
NCT02182011,"A Study to Investigate the Procoagulant Effect of Tenecteplase (TNK-tPA), Alteplase (Rt-PA) and Streptokinase (SK) Administered to Patients With Acute Myocardial Infarction (AMI)",COMPLETED,PHASE3,Myocardial Infarction,DRUG: Tenecteplase; DRUG: Alteplase; DRUG: Streptokinase,INTERVENTIONAL,2000-05,2001-06,
NCT04528368,Convalescent Plasma for Treating Patients With COVID-19 Pneumonia Without Indication of Ventilatory Support,UNKNOWN,PHASE2,COVID-19,BIOLOGICAL: Convalescent plasma,INTERVENTIONAL,2020-12-11,2021-12-30,
NCT04382950,Combination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications,UNKNOWN,PHASE1,COVID,COMBINATION_PRODUCT: Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2) plus Aerosolized 13 cis retinoic acid,INTERVENTIONAL,2021-07,2021-08,
NCT00883584,IMD-1041 Chronic Obstructive Pulmonary Disease: Proof of Concept (POC) Study,UNKNOWN,PHASE2,Chronic Obstructive Pulmonary Disease,DRUG: IMD-1041; DRUG: Placebo,INTERVENTIONAL,2008-07,2009-05,
NCT03433833,Digoxin for Congenital Erythrocytosis Due to Up-Regulated Hypoxia Sensing,WITHDRAWN,PHASE1,Polycythemia; Familial; Erythrocytosis; Familial; VHL Gene Mutation; HIF-2alpha Erythrocytosis; PHD2 Erythrocytosis; Chuvash Erythrocytosis,DRUG: Digoxin,INTERVENTIONAL,2019-11-10,2024-04-16,
NCT02785965,Acupuncture in the Regulation of Dai Meridian for Polycystic Ovarian Syndrome Patients With Abdominal Obesity,UNKNOWN,NA,"Polycystic Ovarian Syndrome; Obesity, Abdominal",DEVICE: electroacupuncture; BEHAVIORAL: lifestyle modification,INTERVENTIONAL,2016-07,2019-01,
NCT02062216,Role of the Inflammatory Receptors in the Pathogenesis of Atherosclerosis,UNKNOWN,,Coronary Artery Disease,,OBSERVATIONAL,2015-02,2017-12,
NCT03236350,Remote Ischaemic Conditioning on Blood Pressure Control in Chronic Kidney Disease Patients,UNKNOWN,NA,Chronic Kidney Diseases; Hypertension; Cardiovascular Diseases,DEVICE: Active autoRIC® (CRIC Treatment); DEVICE: Sham Control autoRIC® (Sham Control),INTERVENTIONAL,2017-11-28,2020-03-31,
NCT04133220,Endothelial Activation Hemostasis Disturbances and Severe Bleeding Events in Hyperleukocytic Acute Myeloid Leukemia,UNKNOWN,,"Leukemia, Myeloid, Acute",,OBSERVATIONAL,2019-10,2022-02,
NCT04351048,Stepwise and One Step Techniques In Deep Dentin Lesion,UNKNOWN,NA,"Dental Caries, Dental Pulp Exposure",PROCEDURE: Stepwise Excavation; PROCEDURE: One Step Excavation,INTERVENTIONAL,2016-12-12,2018-03-02,
